Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2808165165', 'doi': 'https://doi.org/10.1177/2168479018779373', 'title': 'Expediting Drug Development: FDA’s New Regenerative Medicine Advanced Therapy Designation', 'display_name': 'Expediting Drug Development: FDA’s New Regenerative Medicine Advanced Therapy Designation', 'publication_year': 2019, 'publication_date': '2019-05-01', 'ids': {'openalex': 'https://openalex.org/W2808165165', 'doi': 'https://doi.org/10.1177/2168479018779373', 'mag': '2808165165', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/29895180'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1177/2168479018779373', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S1037458212', 'display_name': 'Therapeutic Innovation & Regulatory Science', 'issn_l': '2168-4790', 'issn': ['2168-4790', '2168-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5037893509', 'display_name': 'Annegret Vaggelas', 'orcid': 'https://orcid.org/0000-0003-3578-0054'}, 'institutions': [{'id': 'https://openalex.org/I4210152164', 'display_name': 'Apceth Biopharma (Germany)', 'ror': 'https://ror.org/04zvyjw73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210152164']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Annegret Vaggelas', 'raw_affiliation_strings': ['Biopharma Excellence GmbH, c/o Munich Technology Center, Agnes-Pockels-Bogen 1, Munich, 80992, Germany'], 'affiliations': [{'raw_affiliation_string': 'Biopharma Excellence GmbH, c/o Munich Technology Center, Agnes-Pockels-Bogen 1, Munich, 80992, Germany', 'institution_ids': ['https://openalex.org/I4210152164']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5036376405', 'display_name': 'Diane Seimetz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210152164', 'display_name': 'Apceth Biopharma (Germany)', 'ror': 'https://ror.org/04zvyjw73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I4210152164']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Diane Seimetz', 'raw_affiliation_strings': ['Biopharma Excellence GmbH, c/o Munich Technology Center, Agnes-Pockels-Bogen 1, Munich, 80992, Germany'], 'affiliations': [{'raw_affiliation_string': 'Biopharma Excellence GmbH, c/o Munich Technology Center, Agnes-Pockels-Bogen 1, Munich, 80992, Germany', 'institution_ids': ['https://openalex.org/I4210152164']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2790, 'currency': 'EUR', 'value_usd': 3590, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.405, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 24, 'citation_normalized_percentile': {'value': 0.999957, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '53', 'issue': '3', 'first_page': '364', 'last_page': '373'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13417', 'display_name': 'Regulation of Stem Cell Therapies and Clinics', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13417', 'display_name': 'Regulation of Stem Cell Therapies and Clinics', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'Chimeric Antigen Receptor T Cell Therapy', 'score': 0.9969, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10505', 'display_name': 'Induction and Differentiation of Pluripotent Stem Cells', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/expediting', 'display_name': 'Expediting', 'score': 0.96360636}, {'id': 'https://openalex.org/keywords/drug-development', 'display_name': 'Drug development', 'score': 0.52262336}, {'id': 'https://openalex.org/keywords/regenerative-medicine', 'display_name': 'Regenerative Medicine', 'score': 0.499663}, {'id': 'https://openalex.org/keywords/drug-approval', 'display_name': 'Drug approval', 'score': 0.4953817}, {'id': 'https://openalex.org/keywords/safer', 'display_name': 'SAFER', 'score': 0.4551104}, {'id': 'https://openalex.org/keywords/regulatory-science', 'display_name': 'Regulatory science', 'score': 0.41147134}], 'concepts': [{'id': 'https://openalex.org/C134448949', 'wikidata': 'https://www.wikidata.org/wiki/Q1384274', 'display_name': 'Expediting', 'level': 2, 'score': 0.96360636}, {'id': 'https://openalex.org/C10854531', 'wikidata': 'https://www.wikidata.org/wiki/Q1061415', 'display_name': 'Regenerative medicine', 'level': 3, 'score': 0.5860019}, {'id': 'https://openalex.org/C64903051', 'wikidata': 'https://www.wikidata.org/wiki/Q2198549', 'display_name': 'Drug development', 'level': 3, 'score': 0.52262336}, {'id': 'https://openalex.org/C2992293740', 'wikidata': 'https://www.wikidata.org/wiki/Q4781752', 'display_name': 'Drug approval', 'level': 3, 'score': 0.4953817}, {'id': 'https://openalex.org/C104863432', 'wikidata': 'https://www.wikidata.org/wiki/Q614304', 'display_name': 'Pharmacy', 'level': 2, 'score': 0.45965523}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.45515156}, {'id': 'https://openalex.org/C2776654903', 'wikidata': 'https://www.wikidata.org/wiki/Q2601463', 'display_name': 'SAFER', 'level': 2, 'score': 0.4551104}, {'id': 'https://openalex.org/C112930515', 'wikidata': 'https://www.wikidata.org/wiki/Q4389547', 'display_name': 'Risk analysis (engineering)', 'level': 1, 'score': 0.4543925}, {'id': 'https://openalex.org/C2779652045', 'wikidata': 'https://www.wikidata.org/wiki/Q507443', 'display_name': 'Pharmaceutical industry', 'level': 2, 'score': 0.43671307}, {'id': 'https://openalex.org/C144133560', 'wikidata': 'https://www.wikidata.org/wiki/Q4830453', 'display_name': 'Business', 'level': 0, 'score': 0.42367738}, {'id': 'https://openalex.org/C2778917124', 'wikidata': 'https://www.wikidata.org/wiki/Q7309705', 'display_name': 'Regulatory science', 'level': 2, 'score': 0.41147134}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.2585442}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.24939027}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.2220591}, {'id': 'https://openalex.org/C127413603', 'wikidata': 'https://www.wikidata.org/wiki/Q11023', 'display_name': 'Engineering', 'level': 0, 'score': 0.14993921}, {'id': 'https://openalex.org/C28328180', 'wikidata': 'https://www.wikidata.org/wiki/Q48196', 'display_name': 'Stem cell', 'level': 2, 'score': 0.1292879}, {'id': 'https://openalex.org/C201995342', 'wikidata': 'https://www.wikidata.org/wiki/Q682496', 'display_name': 'Systems engineering', 'level': 1, 'score': 0.07978761}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C512399662', 'wikidata': 'https://www.wikidata.org/wiki/Q3505712', 'display_name': 'Family medicine', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C38652104', 'wikidata': 'https://www.wikidata.org/wiki/Q3510521', 'display_name': 'Computer security', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': 'Q000331', 'qualifier_name': 'legislation & jurisprudence', 'is_major_topic': True}, {'descriptor_ui': 'D007880', 'descriptor_name': 'Legislation, Drug', 'qualifier_ui': 'Q000458', 'qualifier_name': 'organization & administration', 'is_major_topic': True}, {'descriptor_ui': 'D044968', 'descriptor_name': 'Regenerative Medicine', 'qualifier_ui': 'Q000331', 'qualifier_name': 'legislation & jurisprudence', 'is_major_topic': True}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000076722', 'descriptor_name': 'Drug Development', 'qualifier_ui': 'Q000331', 'qualifier_name': 'legislation & jurisprudence', 'is_major_topic': False}, {'descriptor_ui': 'D000076722', 'descriptor_name': 'Drug Development', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007880', 'descriptor_name': 'Legislation, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D044968', 'descriptor_name': 'Regenerative Medicine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1177/2168479018779373', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S1037458212', 'display_name': 'Therapeutic Innovation & Regulatory Science', 'issn_l': '2168-4790', 'issn': ['2168-4790', '2168-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/29895180', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/9', 'score': 0.45, 'display_name': 'Industry, innovation and infrastructure'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 6, 'referenced_works': ['https://openalex.org/W2017664822', 'https://openalex.org/W2343624394', 'https://openalex.org/W2398722604', 'https://openalex.org/W2558879032', 'https://openalex.org/W2598091501', 'https://openalex.org/W2602868956'], 'related_works': ['https://openalex.org/W4311255384', 'https://openalex.org/W4293434046', 'https://openalex.org/W2999793242', 'https://openalex.org/W2523669501', 'https://openalex.org/W2321565583', 'https://openalex.org/W2170721420', 'https://openalex.org/W2132128991', 'https://openalex.org/W2089453005', 'https://openalex.org/W2073146531', 'https://openalex.org/W2061257095'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2808165165', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 1}], 'updated_date': '2024-09-14T18:40:27.906660', 'created_date': '2018-06-21'}